Prostate Cancer International is
for 2011 by Great NonProfits
A research team at the National Institutes of Health and the Johns Hopkins University Bloomberg School of Public Health is seeking prostate cancer patients willing to complete an on-line survey as part of a study to determine how men with prostate cancer cope with their disease, how their quality of life (QoL) is affected, and [...]
Filed under: Living with Prostate Cancer | Tagged: coping, quality of life, research, survey | 2 Comments »
Two weeks ago we let readers know about an article in The New Yorker about end-of-life decision-making. In this week’s issue of the New England Journal of Medicine, there is a report showing that palliative care can extend survival (albeit by only 2-3 months) in lung cancer patients with end-stage disease.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: end of life, palliative care, quality of life, survival | 4 Comments »
According to a media release issued yesterday by the University of North Carolina Lineberger Cancer Center, researchers at this institution have been awarded the first contract we are aware of ”to conduct comparative effectiveness research comparing different management strategies for localized prostate cancer.”
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: comparative effectiveness, localized, outcome, quality of life | 4 Comments »
Today’s news reports include comments on studies dealing with: A compound panel of markers for predicting risk for prostate cancer Open vs. robot-assisted radical prostatectomy: urologists’ perceptions Clinically relevant quality of life assessment after first-line therapy A compound panel of markers for predicting overall survival of patients with CRPC
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: castration-resistant prostate cancer, CRPC, kallikrein, open, prognosis, prostatectomy, quality of life, RALP, risk, robot-assisted, survival | Leave a Comment »
Data to be published in the May 2010 issue of the Journal of Urology are going to make a lot of urologists rather less than happy about the implications for the use of radical prostatectomy as first-line treatment for prostate cancer.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, comparison, cryotherapy, HRQOL, outcome, quality of life, radical prostatectomy, RALP, RP | Leave a Comment »
Today’s news reports summarize papers recently published on: Optimism, pessimism, and long-term health outcomes External beam radiation + hormone therapy for high-risk patients Quality of life and health utility after radical prostatectomy Paclitaxel + estradiol combination therapy in men progressing after docetaxel-based chemotherapy
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", estradiol, hormone therapy, HRQOL, optimism, outcomes, paclitaxel, pessimism, quality of life, radiation, radical prostatectomy | Leave a Comment »
Having high socioeconomic status AND being in a strong, positive, and supportive relationship may have improved the health-related quality of life (HRQOL) of men with localized prostate cancer, according to a recent study.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: HRQOL, partners, quality of life | 1 Comment »
Today’s news reports include items on: Exercise and prostate cancer risk (in mice) Quality of life over 4 years after first-line therapy The adverse effects of long-term hormone therapy
Filed under: Living with Prostate Cancer, Management, Prevention, Treatment, Uncategorized | Tagged: exercise, hormone therapy, Prevention, quality of life, risk | Leave a Comment »
Better understanding of how different men respond to the uncertainty and quality of life issues associated with active surveillance as a method to manage low- and intermediate-risk prostate cancer has the potential to enhance the delivery of care for such patients.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance, quality of life, uncertainty | 2 Comments »
Today’s prostate cancer news reports cover items on: Assessment of quality of life after radical prostatectomy Permanent seed brachytherapy in treatment of localized disease Cryotherapy in treatment of patients with Gleason 8-10 localized disease Actonel and/or estradiol in prevention of SREs
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Actonel, brachytherapy, cryotherapy, estradiol, Gleason score, outcome, permanent, quality of life, risedronate, seed, survey | Leave a Comment »
The “Reach Out to Enhance Wellness” (RENEW) trial was initiated as a randomized multi-center, multi-national trial to actually prove something which many would consider to be “obvious”: the idea that lifestyle modification will help cancer survivors to avoid the risks that they are at for second malignancies, other comorbidities, and accelerated functional decline.
Filed under: Living with Prostate Cancer, Management | Tagged: lifestyle, quality of life, survival | Leave a Comment »
Today’s news reports deal with such items as: Genomic testing for prostate cancer and the value of specific SNPs What do pre-treatment MRI/MRSI tests and molecular profiling add to prognostic significance? Quality of life following salvage brachytherapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: brachytherapy, Diagnosis, genome, MRI, MRSI, prognosis, quality of life, salvage, SNPs | 2 Comments »
The decisions patients and their doctors make about which treatment to select as first-line therapy for localized prostate cancer are commonly based on perceptions and expectations about the side effects of these treatments, as well as on the curative potential of the therapy.
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: comparison, first line, HRQOL, outcomes, quality of life, Treatment | Leave a Comment »
Today’s news reports refer to a series of reviews that appeared this month in a supplement to Urology as well as other articles: 20 years of experience with the PSA test in assessment of risk for prostate cancer Biomarkers in the assessment of future risk for prostate cancer Treatment choice, outcome, and quality of life [...]
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biomarkers, choice, Diagnosis, outcome, prognosis, PSA, quality of life, risk, survival, Treatment | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site